The prescription products will be commercialized in partnership with IPS Pharma, an established company with more than 20 years of experience with unlicensed medicines. TORONTO, Feb....
Canada’s Globe & Mail reports on their court case A years-long access-to-information battle between journalists and Health Canada over data on the locations of large-scale medical cannabis...
In the wilds of North Texas, a K-9 with a keen nose for trouble sniffed out a suspicious pair of travelers, who were hauling a trailer...
Good luck with that , we say! Avis de bon sens rendu par le Cese. En tant que maire confronté aux trafics, je propose à @EmmanuelMacron...
LOVE Hemp has responded to damning allegations made publicly by its former managing director Philip Small, who left the company in November 2022. The Aquis-listed CBD...
BusinessCann YESTERDAY morning Cellular Goods informed investors that its proposed £18.6m reverse-takeover deal with Cannaray has been scrapped. In a brief RNS, the CBD retailer said...
Dear Stakeholders, Welcome to the MED’s first e-Newsletter! We are excited to share this publication with you. We developed this e-newsletter to share recent happenings at the MED,...
FRANKFURT-based medical cannabis holding company Bloomwell Group (“Bloomwell,” “Bloomwell Group,” or the “Company”) has closed a significant multi-million Euro funding round led by Artemis Growth Partners (“Artemis”), a premier American...
This is good to see They Write Please Support SB 302, To Expand Ryan’s Law Protections to Seniors with Chronic Pain SB 302 would expand the...
We talk a lot about the impact that legal cannabis has on different sectors, including the pharmaceutical industry. Now, a study sheds light on what exactly...
